Narula Sanjeev bought PHAT
January 2, 2026 · Form 4 insider transaction
Narula Sanjeev bought 82,715 shares of Phathom Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
82,715
Price
$0.00
Total value
N/A
InsiderNarula Sanjeev
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 2, 2026
Shares owned after226,715
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.